Second, because few RCTs provided HF indicators, including LVEF, BNP, etc., before and after patiromer therapy, the consolidation of relevant data was limited, which made it difficult to assess the benefits of patiromer in reducing potassium and optimizing RAASi therapy. Here, NPPB is linked to hydrops fetalis.